GLP-1受体激活剂作为慢性皮肤伤口愈合中的炎症和血管生成的新兴调节剂
Johanna Ghebrehiwet-Kuflom1, Alisha Mehta2, Pallas Lim3
1Department of Dermatology, University of California Davis Medical Center, Sacramento, California, USA; Dermatology Section, VA Northern California Health Care System, Sacramento, California, USA.
The Journal of investigative dermatology
|October 13, 2025
概括
类似葡萄糖-1受体激动剂 (GLP-1RA) 显示出治疗糖尿病足的潜力. 临床前研究表明,这些药物可以克服关键的愈合障碍,需要进一步的临床研究.
科学领域:
- 内分泌学 在内分泌学.
- 伤口治愈研究研究 伤口治愈研究
- 免疫学 免疫学 免疫学
背景情况:
- 糖尿病足 (DFU) 是一种严重的糖尿病并发症,治疗结果不佳.
- 标准护理往往失败,导致感染和截肢.
- 葡萄糖类-1受体激动剂 (GLP-1RA) 已知有血糖效益和潜在的再生作用.
研究的目的:
- 审查GLP-1RA在皮肤修复中的机制性见解.
- 探索GLP-1RA如何解决DFU愈合中的障碍.
- 评估GLP-1RA作为DFU辅助疗法的潜力.
主要方法:
- 这是一篇关于体外和动物模型研究的叙述性综述.
- 总结了GLP-1RA对炎症和再生通路的作用机制.
- 分析了对免疫细胞,血管生成和上皮质形成的影响的证据.
主要成果:
- GLP-1RA可能会抑制TNF-α和NF-κB信号传递,激活关键修复通路.
- 它们促进了角质细胞迁移,内皮原生细胞功能和修复性巨细胞两极分化.
- 观察到像VEGFR-2和HIF-1α这样的血管性介质的升级.
结论:
- 临床前数据表明GLP-1RA可以解决DFU的主要愈合障碍.
- 需要进一步的临床试验来验证这些发现与标准护理相比.
- GLP-1RA可能为糖尿病足提供一种新的辅助治疗方法.
相关概念视频
Glucagon-like Receptor Agonists
841
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
841
Inflammatory Response
16.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.0K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
460
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
460


